Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (1): 108-114.doi: 10.6040/j.issn.1671-7554.0.2024.0691

• Clinical Research • Previous Articles    

Current status of breast multidisciplinary treatment in 38 tertiary hospitals in Shandong Province, China

AI Xiancheng, WANG Fei, ZHOU Wenzhong, YU Lixiang, ZHOU Fei, XIANG Yujuan, LI Liang, YU Zhigang   

  1. Breast Disease Diagnosis and Treatment Center, The Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Published:2025-02-20

Abstract: Objective To understand the development of breast multidisciplinary treatment(MDT)in tertiary hospitals in Shandong Province, and to promote the standardisation of MDT. Methods A simple random sampling was conducted on 38 tertiary hospitals in Shandong Province. A questionnaire survey was conducted to collect basic information on doctors, hospitals, MDT implementation, and MDT evaluation. The collected data underwent statistical analysis. Results A total of 35 hospitals(92.1%)established breast surgery services, while 17 and 13 established breast imaging and pathology subspecialties, respectively. It is noteworthy that 73.7% of the hospitals have been conducting MDTs for 3 to 10 years, and 47.4% were conducting weekly MDTs. All eight hospitals with well-established subspecialties had been conducting MDTs for more than five years, whereas only three hospitals without two major subspecialties had been conducting MDTs for more than five years. Hospitals with well-established subspecialties had a higher proportion of weekly MDTs. About 94.5% of the respondents believed that MDT optimised clinical diagnosis and treatment, 97.2% supported the establishment of an MDT database, but only 43.6% of hospitals have established a database. Furthermore, 88.2% of the respondents were satisfied with the MDT remuneration, and the difference in the distribution of the respondents satisfaction with different job titles was not statistically significant. Conclusion Breast MDT in tertiary hospitals in Shandong Province has developed earlier, but still needs to be improved continuously, and in the future, it needs to mobilise the enthusiasm of medical workers and further standardise and promote it.

Key words: Breast cancer, Multidisciplinary team, Tertiary hospital, Tumor, Medical quality

CLC Number: 

  • R737.9
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2] 乔江华, 刘真真. 多学科综合治疗助力乳腺癌质量控制规范化[J]. 肿瘤综合治疗电子杂志, 2023, 9(3): 19-22. QIAO Jianghua, LIU Zhenzhen. Multidisciplinary team improve the quality control of breast cancer diagnosis and treatment[J]. Journal of Multidisciplinary Cancer Management(Electronic Version), 2023, 9(3): 19-22.
[3] 刘真真. 《河南省肿瘤诊疗质量控制中心乳腺癌专家委员会专家共识》序言[J]. 中华肿瘤防治杂志, 2023, 30(24): 1459-1460. LIU Zhenzhen. Preface to expert consensus of breast cancer expert committee in Henan cancer diagnostic and treatment quality control center[J]. Chinese Journal of Cancer Prevention and Treatment, 2023, 30(24): 1459-1460.
[4] 孙湛, 杨丽, 邵雨婷, 等. 多学科诊疗模式现状分析与思考[J]. 中国卫生质量管理, 2018, 25(6): 37-40. SUN Zhan, YANG Li, SHAO Yuting, et al. Analysis and thinking on the current situation of multidisciplinary diagnosis and treatment mode[J]. Chinese Health Quality Management, 2018, 25(6): 37-40.
[5] 胡夕春, 王磊苹. 2012年ASCO年会乳腺癌热点报道[J]. 中华乳腺病杂志(电子版), 2012, 6(4): 351-357. HU Xichun, WANG Leiping. Hot report on breast cancer in 2012 ASCO annual meeting[J]. Chinese Journal of Breast Disease(Electronic Edition), 2012, 6(4): 351-357.
[6] 王丹, 莫陶欣, 薛冬, 等. 首批国家肿瘤多学科诊疗试点医院情况分析[J]. 中国肿瘤, 2021, 30(5): 352-356. WANG Dan, MO Taoxin, XUE Dong, et al. Operational status of the first batch of national pilot Units of cancer multidisciplinary team for the diagnosis and treatment[J]. China Cancer, 2021, 30(5): 352-356.
[7] 杨凌鹤, 刘美岑, 曹曼, 等. 我国三级肿瘤医院多学科诊疗模式开展现状调查[J].中国卫生质量管理, 2022, 29(10): 40-44. YANG Linghe, LIU Meicen, CAO Man, et al. Multi-disciplinary team model in Chinas tertiary tumor hospitals: a cross-sectional investigation[J]. Chinese Health Quality Management, 2022, 29(10): 40-44.
[8] 中华人民共和国国家卫生和计划生育委员会. 关于加强肿瘤规范化诊疗管理工作的通知[EB/OL].(2016-09-28)[2024-06-30]. http://www.nhc.gov.cn/bgt/2016dsq/201609/0578f2ecbdd54e96a204bb2479b89a5f.shtml.
[9] 中华人民共和国国家卫生和计划生育委员会,国家中医药管理局.关于印发进一步改善医疗服务行动计划(2018—2020年)的通知[EB/OL].(2017-12-29)[2024-06-30]. https://www.gov.cn/gongbao/content/2018/content_5299607.htm.
[10] Fleissig A, Jenkins V, Catt S, et al. Multidisciplinary teams in cancer care: are they effective in the UK?[J]. Lancet Oncol, 2006, 7(11): 935-943.
[11] Friedman EL, Chawla N, Morris PT, et al. Assessing the development of multidisciplinary care: experience of the national cancer institute community cancer centers program[J]. J Oncol Pract, 2015, 11(1): e36-e43.
[12] Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline[J]. J Clin Oncol, 2021, 39(13): 1485-1505.
[13] 郝婧灿, 何幡, 李娜, 等. 综合医院肿瘤多学科诊疗质量管理的现状及分析[J]. 现代医院管理, 2022, 20(4): 28-31. HAO Jingcan, HE Fan, LI Na, et al. Status quo and analysis of quality management of multidisciplinary diagnosis and treatment for tumors in comprehensive hospitals[J]. Modern Hospital Management, 2022, 20(4): 28-31.
[14] 余松轩, 赵蓉, 李贤华, 等. 上海市医院多学科诊疗模式标准研制与思考[J]. 中国卫生质量管理, 2021, 28(12): 14-17. YU Songxuan, ZHAO Rong, LI Xianhua, et al. Development and consideration of multi-disciplinary treatment mode standard in hospitals in Shanghai[J]. Chinese Health Quality Management, 2021, 28(12): 14-17.
[15] 林芸, 谢燕秋. 乳腺癌患者生育力保护及保存[J]. 山东大学学报(医学版), 2022, 60(9): 42-46. LIN Yun, XIE Yanqiu. Fertility protection and preservation in breast cancer patients[J]. Journal of Shandong University(Health Sciences), 2022, 60(9): 42-46.
[16] Ueno NT, Ito TD, Grigsby RK, et al. ABC conceptual model of effective multidisciplinary cancer care[J]. Nat Rev Clin Oncol, 2010, 7(9): 544-547.
[17] Capobianco AML, Gallucci G, Lapadula L, et al. Impact of the multidisciplinary cancer team on the diagnostic and therapeutic care pathway of early breast cancer patients and perception of team members: the experience of a cancer centre in Italy[J]. Cancer Invest, 2024, 42(1): 12-20.
[18] Pangarsa EA, Rizky D, Tandarto K, et al. The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis[J]. Ann Med Surg, 2023, 85(6): 2940-2948.
[19] 辛灵, 向泓雨, 叶京明, 等. 《肿瘤专业医疗质量控制指标(2023年版)》与乳腺外科热点问题[J]. 中华外科杂志, 2024, 62(2): 93-98. XIN Ling, XIANG Hongyu, YE Jingming, et al. Quality Control Indexes for Oncology(2023 edition)and hot topics in breast surgery[J]. Chinese Journal of Surgery, 2024, 62(2): 93-98.
[20] 孟利伟, 楼亦锜, 章蔚, 等. 多学科诊疗模式对乳腺癌术后辅助化疗决策的影响及相关因素分析[J]. 中华内分泌外科杂志, 2019, 13(5): 408-412. MENG Liwei, LOU Yiqi, ZHANG Wei, et al. The influence of multidisciplinary team on adjuvant chemotherapy for postoperative breast cancer patients[J]. Chinese Journal of Endocrine Surgery, 2019, 13(5): 408-412.
[21] 周亚杰, 王斐, 于理想, 等. 女性乳腺癌保乳手术决策相关因素[J]. 山东大学学报(医学版), 2022, 60(12): 1-6. ZHOU Yajie, WANG Fei, YU Lixiang, et al. Factors related to decision-making of breast-conserving surgery for female breast cancer[J]. Journal of Shandong University(Health Sciences), 2022, 60(12): 1-6.
[22] 沈坤炜, 李宏为. 乳腺癌的现代治疗模式:多学科综合诊治[J]. 外科理论与实践, 2014, 19(5): 369-371. SHEN Kunwei, LI Hongwei. Modern treatment model of breast cancer: multidisciplinary comprehensive diagnosis and treatment[J]. Journal of Surgery Concepts & Practice, 2014, 19(5): 369-371.
[23] Baldwin LM, Taplin SH, Friedman H, et al. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?[J]. Cancer, 2004, 100(4): 701-709.
[24] Chan WF, Cheung PS, Epstein RJ, et al. Multidisciplinary approach to the management of breast cancer in Hong Kong[J]. World J Surg, 2006, 30(12): 2095-2100.
[25] 国家肿瘤质控中心乳腺癌专家委员会. 中国乳腺癌规范诊疗质量控制指标(2022版)[J]. 中华肿瘤杂志, 2022, 44(3): 203-208. Breast Cancer Expert Committee of National Cancer Quality Control Center. Quality control index for standardized diagnosis and treatment of breast cancer in China(2022 Edition)[J]. Chinese Journal of Oncology, 2022, 44(3): 203-208.
[26] 郭晓培, 王平. 北京某医院医患双方对MDT诊疗模式的认知调查[J]. 医院管理论坛, 2021, 38(3): 42-46. GUO Xiaopei, WANG Ping. Investigation on cognition of MDT diagnosis and treatment model in doctors and patients in a Beijing hospital[J]. Hospital Management Forum, 2021, 38(3): 42-46.
[27] Saini KS, Taylor C, Ramirez AJ, et al. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries[J]. Ann Oncol, 2012, 23(4): 853-859.
[28] 杨凌鹤, 温中一, 刘美岑, 等. 我国40家三级公立医院多学科诊疗模式经验总结[J]. 中华医院管理杂志, 2021, 37(6): 505-508. YANG Linghe, WEN Zhongyi, LIU Meicen, et al. Experience of multi-disciplinary team mode in 40 tertiary public hospitals in China[J]. Chinese Journal of Hospital Administration, 2021, 37(6): 505-508.
[29] 赋能专科建设—共创健康中国多学科专家委员会,中国抗癌协会乳腺癌专业委员会. 乳腺癌多学科诊疗标准与规范(2023年版)[J]. 中国癌症杂志, 2023, 33(12): 1188-1203. Energizing Specialty Construction-Multidisciplinary Expert Committee for Creating Healthy China, The Society of Breast Cancer China Anti-Cancer Association. Standardization of multi disciplinary team treatment for breast cancer(2023 edition)[J]. China Oncology, 2023, 33(12): 1188-1203.
[30] 王佳妮, 欧开萍, 刘嘉琦, 等. 乳腺癌多学科综合诊疗模式的能力建设及发展趋势[J]. 中国普通外科杂志, 2023, 32(5): 656-664. WANG Jiani, OU Kaiping, LIU Jiaqi, et al. Capacity building and development trends of the multidisciplinary integrated treatment model for breast cancer[J]. Chinese Journal of General Surgery, 2023, 32(5): 656-664.
[1] WANG Wei, WANG Yi-Feng, ZHANG Ling-Mei, LIN Qiong-Yan, HUANG Ju. umorigenicity and invasion of side population in human ovarian epithelial cancer OVCAR3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 8-11.
[2] LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61.
[3] ZOU Yujin, WAN Yi, JI Zhenbing, LIANG Xichang. Biological experimental study on a dual-functional titanium alloy implant for promoting bone regeneration and antitumor therapy [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 50-65.
[4] GU Chunqing, GUO Ruisi, ZHOU Qinqin, LIU Henghui, BA Wanyu, SUN Shiling, WANG Bing, ZHENG Yuling, WU Suhui. Mechanism of Suanzaoren-Yuanzhi drug pair in the treatment of breast cancer related insomnia based on network pharmacology and animal experiments [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 99-108.
[5] LI Xuekai, SUN Linhan, LIU Duanrui, NI Yang. Research progress on the function and mechanism of lactylation in the process of tumor inflammation and cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 65-76.
[6] LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74.
[7] WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54.
[8] WANG Xuemei, YANG Hao, SONG Yang, CHENG Shichao, ZHANG Tingting, WANG Yanchun. Causal association of antidiabetic drugs with female malignant tumours: a two-sample Mendelian randomisation study [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 67-77.
[9] ZHAO Hanqing, ZHOU Xinrui, LI Zijian, TANG Xing. Application of circulating tumor cells combined with serological detection in non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 79-85.
[10] DU Xue, LI Chunxia, LIU Yunxia, ZHANG Tao. Dynamic prediction model for the colorectal cancer patients prognosis based on MFPC-Cox [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 101-110.
[11] YU Zhigang, ZHENG Chao. Current status, challenges and innovative approaches of multidisciplinary treatment for breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 1-9.
[12] . Shandong Province expert consensus on multidisciplinary treatment of breast cancer(2024 edition) [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 10-16.
[13] CHENG Yueqi, WANG Fei, YU Lixiang, ZHENG Chao, YU Zhigang. Progress in the study of trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 17-24.
[14] WANG Min, LI Xiping, TAN Jun, QIU Mei, HOU Zeyu, TIAN Ying, LUO Hongying, FAN Chaowen, QI Ling, YU Qi, XIE Wei. Lentivirus vector-mediated Gag-Caspase-8 induces apoptosis and S-phase arrest in triple-negative breast cancer primary cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 25-34.
[15] ZHANG Jie, ZHANG Fangfang, WANG Jingnan, LI Zeyu, SONG Ying, LI Na. Expression of circ_0000144 in breast cancer and its effect on the proliferation, migration and invasion ability of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 35-42.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!